Alex Lower, PA
Medical · Lynchburg, VANPI 1205406865
Payments from drug & device makers
Across 148 payments — averaging $28.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- AstraZeneca$498
- GSK$374
- Amgen$277
- Sanofi$259
- Harmony Biosciences LLC$160
- plus $1K from 21 others
What the payments were for
- Travel & lodging$1,05125%
- Food & beverage$3,10173%
- Education$792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,445 |
| AstraZeneca | 28 | $498 |
| GSK | 26 | $374 |
| Amgen | 13 | $277 |
| Sanofi | 10 | $259 |
| Harmony Biosciences LLC | 6 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $151 |
| United Therapeutics Corporation | 6 | $125 |
| Merck | 4 | $120 |
| Boehringer Ingelheim | 4 | $103 |
| Pfizer | 6 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Philips North America LLC | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Baxter Healthcare | 3 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $51 |
| Grifols USA, LLC | 2 | $47 |
| Novartis | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Electromed, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Inogen, Inc. | 1 | $19 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,065
How this compares
$4,231 in reported general payments places this provider in the 85th percentile of 632 medical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 298 | $308,388 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 155 | $104,719 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 68 | $73,792 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 78 | $59,959 |
| Breo ElliptaFluticasone/Vilanterol | 97 | $53,960 |
| Spiriva RespimatTiotropium Bromide | 51 | $41,963 |
| EliquisApixaban | 17 | $18,344 |
| Spiriva HandihalerTiotropium Bromide | 16 | $17,080 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $11,796 |
| Wixela InhubFluticasone Propion/Salmeterol | 52 | $11,364 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 253 | $8,897 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $8,681 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 48 | $8,064 |
| Arnuity ElliptaFluticasone Furoate | 18 | $7,397 |
| Roflumilast | 38 | $6,504 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $374 | $483,144580 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $103 | $101,922129 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $498 | $85,58996 claims |
| PfizerEliquis | $102 | $18,34417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 632 medical providers in Virginia.
Other medical in Lynchburg
- Seth JonesLynchburg$7K
- Bryan UrquhartFredericksburg$264K
- Sara VillalonaRichmond$240K
- Sarah SafaLansdowne$171K
- Waseem GarbiaFairfax$114K
- Rana HassanAshburn$54K
- Brian LamFalls Church$51K
- Christine KesslerKing George$20K
- Janlyn AnthonyRichmond$18K
- Cara DepanfilisNorfolk$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.